Michael E. Williams is the Byrd S. Leavell Professor of Medicine at the University of Virginia Comprehensive Cancer Center, Charlottesville.

Dr. Williams received his MD from the University of Cincinnati College of Medicine and a Master of Science from the Harvard School of Public Health. After completing medicine residency, chief residency, and Hematology/Oncology fellowship at the University of Virginia, he joined the Department of Medicine and the National Cancer Institute–designated Comprehensive Cancer Center.

Dr. Williams’ research interests include novel therapeutic approaches for chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas, with a focus on mantle cell lymphoma, targeted oral agents and immunotherapeutics. He is an Emeritus member of the Scientific Advisory Board of the Lymphoma Research Foundation, and received the inaugural LRF Mantle Cell Lymphoma Leadership Award in 2021. He is a member of the Eastern Cooperative Oncology Group Lymphoma Core Committee.

Dr. Williams is past Chair of the Hematology Subspecialty Board of the American Board of Internal Medicine, served on the ABIM Council, and is a current member of the Hematology Longitudinal Knowledge Assessment Committee. He participates regularly in national and international programs devoted to education and research in lymphoma and CLL.